Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
Oriol Manuel(University of Lausanne), Atul Humar, Belinda Yen‐Lieberman(Cleveland Clinic), A. Sébastian(University of Oklahoma Health Sciences Center), Luiz F. Lisboa(University of Alberta), Marilyn E. Levi(University of Colorado Anschutz Medical Campus), Dinesh Kumar(University of Alberta), Carlos Zayas(Prisma Health), Brian S. Schwartz(University of California, San Francisco), Daniel Kaul(University of Michigan), Michael G. Ison(National Institutes of Health), Leticia Ely(University of Alberta), Jayant Kalpoe(Leiden University), Shahid Husain(University Health Network), Michele I. Morris(University of Miami), Maha Assi(University of Kansas), S D Mawhorter(Cleveland Clinic)
Cited by 299
Related Papers
Glomerular Involvement in Adults with Sickle Cell Hemoglobinopathies
|Journal of the American Society of Nephrology|2006|236
Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum
|Clinical Infectious Diseases|2024|145
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study
|American Journal of Transplantation|2020|134
A Randomized Trial to Reduce Disparities in Referral for Transplant Evaluation
|Journal of the American Society of Nephrology|2016|119
Dialysis facility referral and start of evaluation for kidney transplantation among patients treated with dialysis in the Southeastern United States
|American Journal of Transplantation|2020|94